BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 9330420)

  • 21. The 5 W's of surfactant for respiratory distress syndrome of the premature infant.
    Parmigiani S
    J Matern Fetal Neonatal Med; 2004 Nov; 16 Suppl 2():25-7. PubMed ID: 15590430
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aerosolized surfactants.
    Mazela J; Merritt TA; Finer NN
    Curr Opin Pediatr; 2007 Apr; 19(2):155-62. PubMed ID: 17496758
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Surfactant therapy of premature infants. Complications and mortality are reduced].
    Hjalmarson O
    Lakartidningen; 1993 Nov; 90(45):3938-40. PubMed ID: 8231562
    [No Abstract]   [Full Text] [Related]  

  • 24. Minimally invasive surfactant therapy with a gastric tube is as effective as the intubation, surfactant, and extubation technique in preterm babies.
    Aguar M; Cernada M; Brugada M; Gimeno A; Gutierrez A; Vento M
    Acta Paediatr; 2014 Jun; 103(6):e229-33. PubMed ID: 24628379
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Avoidance of mechanical ventilation by surfactant treatment of spontaneously breathing preterm infants (AMV): an open-label, randomised, controlled trial.
    Göpel W; Kribs A; Ziegler A; Laux R; Hoehn T; Wieg C; Siegel J; Avenarius S; von der Wense A; Vochem M; Groneck P; Weller U; Möller J; Härtel C; Haller S; Roth B; Herting E;
    Lancet; 2011 Nov; 378(9803):1627-34. PubMed ID: 21963186
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Substitutive therapy with surfactants in premature infants with respiratory distress syndrome].
    Liberatore A; Carrera G; Calciolari G; Coccia C; Coppalini B; Fulconis F; Moro G; Scimone F; Villa G; Minoli I
    Ann Osp Maria Vittoria Torino; 1987-1988; 30():28-35. PubMed ID: 3334194
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evolution of surfactant therapy for respiratory distress syndrome: past, present, and future.
    Sardesai S; Biniwale M; Wertheimer F; Garingo A; Ramanathan R
    Pediatr Res; 2017 Jan; 81(1-2):240-248. PubMed ID: 27706130
    [TBL] [Abstract][Full Text] [Related]  

  • 28. How best to administer surfactant to VLBW infants?
    Kribs A
    Arch Dis Child Fetal Neonatal Ed; 2011 Jul; 96(4):F238-40. PubMed ID: 21444298
    [No Abstract]   [Full Text] [Related]  

  • 29. Supraglottic Atomization of Surfactant in Spontaneously Breathing Lambs Receiving Continuous Positive Airway Pressure.
    Milesi I; Tingay DG; Lavizzari A; Bianco F; Zannin E; Tagliabue P; Mosca F; Ventura ML; Rajapaksa A; Perkins EJ; Black D; Di Castri M; Sourial M; Pohlmann G; Dellaca' RL
    Pediatr Crit Care Med; 2017 Sep; 18(9):e428-e434. PubMed ID: 28742723
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Use of surfactant in respiratory diseases in neonates and infants].
    Marraro G
    Cah Anesthesiol; 1994; 42(2):159-66. PubMed ID: 8087630
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Surfactant replacement therapy with a minimally invasive technique: Experience in a tertiary hospital].
    Canals Candela FJ; Vizcaíno Díaz C; Ferrández Berenguer MJ; Serrano Robles MI; Vázquez Gomis C; Quiles Durá JL
    An Pediatr (Barc); 2016 Feb; 84(2):79-84. PubMed ID: 26028565
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome.
    Stevens TP; Blennow M; Soll RF
    Cochrane Database Syst Rev; 2004; (3):CD003063. PubMed ID: 15266470
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changes in pulmonary mechanics after the administration of surfactant to infants with respiratory distress syndrome.
    Davis JM; Veness-Meehan K; Notter RH; Bhutani VK; Kendig JW; Shapiro DL
    N Engl J Med; 1988 Aug; 319(8):476-9. PubMed ID: 3405254
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Minimally invasive surfactant administration in preterm infants: a meta-narrative review.
    More K; Sakhuja P; Shah PS
    JAMA Pediatr; 2014 Oct; 168(10):901-8. PubMed ID: 25089718
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early administration of the second surfactant dose in preterm infants with severe respiratory distress syndrome.
    Köksal N; Akpinar R; Cetinkaya M
    Turk J Pediatr; 2009; 51(6):556-64. PubMed ID: 20196389
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Surfactant replacement therapy for preterm and term neonates with respiratory distress.
    Polin RA; Carlo WA; ;
    Pediatrics; 2014 Jan; 133(1):156-63. PubMed ID: 24379227
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Lung function in premature infants can be improved. Surfactant therapy and CPAP reduce the need of respiratory support].
    Blennow M; Jonsson B; Dahlström A; Sarman I; Bohlin K; Robertson B
    Lakartidningen; 1999 Mar; 96(13):1571-6. PubMed ID: 10218338
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Surfactant replacement therapy in neonatal respiratory distress syndrome.
    Hellmann J
    Paediatr Anaesth; 1995; 5(2):81-8. PubMed ID: 7489429
    [No Abstract]   [Full Text] [Related]  

  • 39. LISA: Surfactant administration in spontaneous breathing. Which evidence from the literature?
    Lista G; La Verde A; Castoldi F
    Acta Biomed; 2015 Jun; 86 Suppl 1():24-6. PubMed ID: 26135952
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Surfactant and ambroxol in the therapy of idiopathic respiratory syndrome in newborn infants].
    Carrera G; Liberatore A; Riboni G; Clementi M
    Minerva Pediatr; 1991 Nov; 43(11):723-30. PubMed ID: 1791799
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.